InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (45 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
45
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Betz Stephen F., Directeur Scientifique. Director active across 1 company, notably Crinetics Pharmaceuticals, Inc.. In total, 56 disclosures have been published. Split: 0 buy · 45 sells. Total volume traded: €4.6m. History available since 21 October 2021. The latest transaction was filed on 16 March 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Betz Stephen F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations56 total
6,371 shares@ US$37.114.2% of flowCommon StockSEC:0001628280-26-019498:0
30,000 shares0Common StockSEC:0001628280-26-011718:0
18,000 shares@ US$1.910.6% of flowCommon StockSEC:0001628280-25-059009:0
71,525 shares@ US$1.912.5% of flowCommon StockSEC:0000950170-25-086804:0
5,479 shares@ US$34.172.9% of flowCommon StockSEC:0000950170-25-043402:0
43,000 shares0Common StockSEC:0000950170-25-025664:0
2,331 shares@ US$1.910.1% of flowCommon StockSEC:0000950170-24-137923:0
1,035 shares@ US$51.500.8% of flowCommon StockSEC:0000950170-24-105952:0
3,000 shares@ US$53.192.4% of flowCommon StockSEC:0000950170-24-101434:0
3,000 shares@ US$47.682.2% of flowCommon StockSEC:0000950170-24-097085:0
3,000 shares@ US$53.432.5% of flowCommon StockSEC:0000950170-24-086935:0
3,000 shares@ US$48.552.3% of flowCommon StockSEC:0000950170-24-083221:0
3,000 shares@ US$45.372.2% of flowCommon StockSEC:0000950170-24-077905:0
3,000 shares@ US$43.862.1% of flowCommon StockSEC:0000950170-24-071971:0
3,000 shares@ US$47.492.2% of flowCommon StockSEC:0000950170-24-066657:0
3,000 shares@ US$49.432.3% of flowCommon StockSEC:0000950170-24-059865:0
3,655 shares@ US$38.142.2% of flowCommon StockSEC:0001209191-24-005010:0
23,000 shares0Common StockSEC:0001209191-24-004604:0
3,000 shares@ US$37.261.8% of flowCommon StockSEC:0001209191-24-002314:0
3,000 shares@ US$37.651.8% of flowCommon StockSEC:0001209191-24-001510:0
3,000 shares@ US$35.891.7% of flowCommon StockSEC:0001209191-23-059809:0
3,000 shares@ US$32.871.6% of flowCommon StockSEC:0001209191-23-058503:0
3,000 shares@ US$31.841.5% of flowCommon StockSEC:0001209191-23-056904:0
1,410 shares@ US$17.120.4% of flowCommon StockSEC:0001209191-23-019760:0
23,600 shares0Common StockSEC:0001209191-23-015578:0
25 of 56 declarations
About Betz Stephen F.
Betz Stephen F. is Chief Scientific Officer at Crinetics Pharmaceuticals, Inc. The 56 filings on record, all within the sampled set, concern sales, with 0 EUR of purchases and 4615432 EUR of sales between 2021-10-25 and 2026-03-18.
